{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:03:13Z","timestamp":1787727793413,"version":"build-2784847793"},"reference-count":109,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,1,27]],"date-time":"2017-01-27T00:00:00Z","timestamp":1485475200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s00134-017-4677-4","type":"journal-article","created":{"date-parts":[[2017,1,27]],"date-time":"2017-01-27T06:43:13Z","timestamp":1485499393000},"page":"496-508","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Sepsis: frontiers in supportive care, organisation and research"],"prefix":"10.1007","volume":"43","author":[{"given":"Anders","family":"Perner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Rhodes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bala","family":"Venkatesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek C.","family":"Angus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Martin-loeches","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Charles","family":"Preiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad","family":"Reinhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Joannidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Opal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,27]]},"reference":[{"key":"4677_CR1","doi-asserted-by":"publisher","first-page":"e446","DOI":"10.1097\/CCM.0000000000001582","volume":"44","author":"N Kissoon","year":"2016","unstructured":"Kissoon N, Daniels R, van der Poll T et al (2016) Sepsis\u2014the final common pathway to death from multiple organ failure in infection. Crit Care Med 44:e446. doi: 10.1097\/CCM.0000000000001582","journal-title":"Crit Care Med"},{"key":"4677_CR2","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/S0140-6736(16)31012-1","volume":"388","author":"H Wang","year":"2015","unstructured":"Wang H, Naghavi M, Allen C et al (2015) Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980\u20132015: a systematic analysis for the global burden of disease study. Lancet 388:1459\u20131544. doi: 10.1016\/S0140-6736(16)31012-1","journal-title":"Lancet"},{"key":"4677_CR3","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1097\/CCM.0b013e31819c13ac","volume":"37","author":"S Karlsson","year":"2009","unstructured":"Karlsson S, Ruokonen E, Varpula T et al (2009) Long-term outcome and quality-adjusted life years after severe sepsis. Crit Care Med 37:1268\u20131274. doi: 10.1097\/CCM.0b013e31819c13ac","journal-title":"Crit Care Med"},{"key":"4677_CR4","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s00134-014-3311-y","volume":"40","author":"A Perner","year":"2014","unstructured":"Perner A, Haase N, Winkel P et al (2014) Long-term outcomes in patients with severe sepsis randomised to resuscitation with hydroxyethyl starch 130\/0.42 or Ringer\u2019s acetate. Intensive Care Med 40:927\u2013934. doi: 10.1007\/s00134-014-3311-y","journal-title":"Intensive Care Med"},{"key":"4677_CR5","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1164\/rccm.201403-0471OC","volume":"190","author":"HC Prescott","year":"2014","unstructured":"Prescott HC, Langa KM, Liu V et al (2014) Increased 1-year healthcare use in survivors of severe sepsis. Am J Respir Crit Care Med 190:62\u201369. doi: 10.1164\/rccm.201403-0471OC","journal-title":"Am J Respir Crit Care Med"},{"key":"4677_CR6","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1007\/s00134-016-4577-z","volume":"42","author":"A Perner","year":"2016","unstructured":"Perner A, Gordon AC, De Backer D et al (2016) Sepsis: frontiers in diagnosis, resuscitation and antibiotic therapy. Intensive Care Med 42:1958\u20131969. doi: 10.1007\/s00134-016-4577-z","journal-title":"Intensive Care Med"},{"key":"4677_CR7","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.2147\/DDDT.S78757","volume":"9","author":"I Martin-Loeches","year":"2015","unstructured":"Martin-Loeches I, Levy MM, Artigas A (2015) Management of severe sepsis: advances, challenges, and current status. Drug Des Dev Ther 9:2079\u20132088. doi: 10.2147\/DDDT.S78757","journal-title":"Drug Des Dev Ther"},{"key":"4677_CR8","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000002091","author":"T Monro-Somerville","year":"2016","unstructured":"Monro-Somerville T, Sim M, Ruddy J et al (2016) The effect of high-flow nasal cannula oxygen therapy on mortality and intubation rate in acute respiratory failure: a systematic review and meta-analysis. Crit Care Med. doi: 10.1097\/CCM.0000000000002091","journal-title":"Crit Care Med"},{"key":"4677_CR9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/MCC.0000000000000270","volume":"22","author":"G Murias","year":"2016","unstructured":"Murias G, Lucangelo U, Blanch L (2016) Patient-ventilator asynchrony. Curr Opin Crit Care 22:53\u201359. doi: 10.1097\/MCC.0000000000000270","journal-title":"Curr Opin Crit Care"},{"key":"4677_CR10","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s00134-015-3692-6","volume":"41","author":"L Blanch","year":"2015","unstructured":"Blanch L, Villagra A, Sales B et al (2015) Asynchronies during mechanical ventilation are associated with mortality. Intensive Care Med 41:633\u2013641. doi: 10.1007\/s00134-015-3692-6","journal-title":"Intensive Care Med"},{"key":"4677_CR11","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/aas.12449","volume":"59","author":"J Claesson","year":"2015","unstructured":"Claesson J, Freundlich M, Gunnarsson I et al (2015) Scandinavian clinical practice guideline on mechanical ventilation in adults with the acute respiratory distress syndrome. Acta Anaesthesiol Scand 59:286\u2013297. doi: 10.1111\/aas.12449","journal-title":"Acta Anaesthesiol Scand"},{"key":"4677_CR12","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/aas.12713","volume":"60","author":"J Claesson","year":"2016","unstructured":"Claesson J, Freundlich M, Gunnarsson I et al (2016) Scandinavian clinical practice guideline on fluid and drug therapy in adults with acute respiratory distress syndrome. Acta Anaesthesiol Scand 60:697\u2013709. doi: 10.1111\/aas.12713","journal-title":"Acta Anaesthesiol Scand"},{"key":"4677_CR13","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1007\/s00134-014-3413-6","volume":"40","author":"EA Suzumura","year":"2014","unstructured":"Suzumura EA, Figueir\u00f3 M, Normilio-Silva K et al (2014) Effects of alveolar recruitment maneuvers on clinical outcomes in patients with acute respiratory distress syndrome: a systematic review and meta-analysis. Intensive Care Med 40:1227\u20131240. doi: 10.1007\/s00134-014-3413-6","journal-title":"Intensive Care Med"},{"key":"4677_CR14","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1056\/NEJMsa1410639","volume":"372","author":"MBP Amato","year":"2015","unstructured":"Amato MBP, Meade MO, Slutsky AS et al (2015) Driving pressure and survival in the acute respiratory distress syndrome. N Engl J Med 372:747\u2013755. doi: 10.1056\/NEJMsa1410639","journal-title":"N Engl J Med"},{"key":"4677_CR15","doi-asserted-by":"publisher","first-page":"531.e1","DOI":"10.1016\/j.jcrc.2012.11.021","volume":"28","author":"A Cheng","year":"2013","unstructured":"Cheng A, Sun H-Y, Lee C-W et al (2013) Survival of septic adults compared with nonseptic adults receiving extracorporeal membrane oxygenation for cardiopulmonary failure: a propensity-matched analysis. J Crit Care 28:531.e1\u2013531.e10. doi: 10.1016\/j.jcrc.2012.11.021","journal-title":"J Crit Care"},{"key":"4677_CR16","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s00134-012-2805-8","volume":"39","author":"MJ Schultz","year":"2013","unstructured":"Schultz MJ, Juffermans NP, Matthay MA (2013) From protective ventilation to super-protective ventilation for acute respiratory distress syndrome. Intensive Care Med 39:963\u2013965. doi: 10.1007\/s00134-012-2805-8","journal-title":"Intensive Care Med"},{"key":"4677_CR17","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.beem.2011.04.010","volume":"25","author":"PMS Clark","year":"2011","unstructured":"Clark PMS, Gordon K (2011) Challenges for the endocrine laboratory in critical illness. Best Pract Res Clin Endocrinol Metab 25:847\u2013859. doi: 10.1016\/j.beem.2011.04.010","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"4677_CR18","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.beem.2011.04.007","volume":"25","author":"B Venkatesh","year":"2011","unstructured":"Venkatesh B, Cohen J (2011) Adrenocortical (dys)function in septic shock\u2014a sick euadrenal state. Best Pract Res Clin Endocrinol Metab 25:719\u2013733. doi: 10.1016\/j.beem.2011.04.007","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"4677_CR19","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1056\/NEJM199909093411102","volume":"341","author":"J Takala","year":"1999","unstructured":"Takala J, Ruokonen E, Webster NR et al (1999) Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 341:785\u2013792. doi: 10.1056\/NEJM199909093411102","journal-title":"N Engl J Med"},{"key":"4677_CR20","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1056\/NEJMoa0810625","volume":"360","author":"S Finfer","year":"2009","unstructured":"Finfer S, Chittock DR, NICE-SUGAR Study Investigators et al (2009) Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360:1283\u20131297. doi: 10.1056\/NEJMoa0810625","journal-title":"N Engl J Med"},{"key":"4677_CR21","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1007\/s00134-015-3899-6","volume":"41","author":"M Volbeda","year":"2015","unstructured":"Volbeda M, Wetterslev J, Gluud C et al (2015) Glucocorticosteroids for sepsis: systematic review with meta-analysis and trial sequential analysis. Intensive Care Med 41:1220\u20131234. doi: 10.1007\/s00134-015-3899-6","journal-title":"Intensive Care Med"},{"key":"4677_CR22","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1056\/NEJMoa052521","volume":"354","author":"G Berghe Van den","year":"2006","unstructured":"Van den Berghe G, Wilmer A, Hermans G et al (2006) Intensive insulin therapy in the medical ICU. N Engl J Med 354:449\u2013461. doi: 10.1056\/NEJMoa052521","journal-title":"N Engl J Med"},{"key":"4677_CR23","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/jama.288.7.862","volume":"288","author":"D Annane","year":"2002","unstructured":"Annane D, S\u00e9bille V, Charpentier C et al (2002) Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288:862\u2013871","journal-title":"JAMA"},{"key":"4677_CR24","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa071366","volume":"358","author":"CL Sprung","year":"2008","unstructured":"Sprung CL, Annane D, Keh D et al (2008) Hydrocortisone therapy for patients with septic shock. N Engl J Med 358:111\u2013124. doi: 10.1056\/NEJMoa071366","journal-title":"N Engl J Med"},{"key":"4677_CR25","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1001\/jama.2016.14799","volume":"316","author":"D Keh","year":"2016","unstructured":"Keh D, Trips E, Marx G et al (2016) Effect of hydrocortisone on development of shock among patients with severe sepsis: the HYPRESS randomized clinical trial. JAMA 316:1775\u20131785. doi: 10.1001\/jama.2016.14799","journal-title":"JAMA"},{"key":"4677_CR26","first-page":"83","volume":"15","author":"B Venkatesh","year":"2013","unstructured":"Venkatesh B, Myburgh J, Finfer S et al (2013) The ADRENAL study protocol: adjunctive corticosteroid treatment in critically ill patients with septic shock. Crit Care Resusc 15:83\u201388","journal-title":"Crit Care Resusc"},{"key":"4677_CR27","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1001\/jama.2014.13204","volume":"312","author":"K Amrein","year":"2014","unstructured":"Amrein K, Schnedl C, Holl A et al (2014) Effect of high-dose vitamin D3 on hospital length of stay in critically ill patients with vitamin D deficiency: the VITdAL-ICU randomized clinical trial. JAMA 312:1520\u20131530. doi: 10.1001\/jama.2014.13204","journal-title":"JAMA"},{"key":"4677_CR28","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1164\/rccm.201410-1864OC","volume":"191","author":"HR Wong","year":"2015","unstructured":"Wong HR, Cvijanovich NZ, Anas N et al (2015) Developing a clinically feasible personalized medicine approach to pediatric septic shock. Am J Respir Crit Care Med 191:309\u2013315. doi: 10.1164\/rccm.201410-1864OC","journal-title":"Am J Respir Crit Care Med"},{"key":"4677_CR29","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1097\/CCM.0000000000001633","volume":"44","author":"J Cohen","year":"2016","unstructured":"Cohen J, Pretorius CJ, Ungerer JPJ et al (2016) Glucocorticoid sensitivity is highly variable in critically ill patients with septic shock and is associated with disease severity. Crit Care Med 44:1034\u20131041. doi: 10.1097\/CCM.0000000000001633","journal-title":"Crit Care Med"},{"key":"4677_CR30","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1007\/s00134-014-3287-7","volume":"40","author":"MP Plummer","year":"2014","unstructured":"Plummer MP, Bellomo R, Cousins CE et al (2014) Dysglycaemia in the critically ill and the interaction of chronic and acute glycaemia with mortality. Intensive Care Med 40:973\u2013980. doi: 10.1007\/s00134-014-3287-7","journal-title":"Intensive Care Med"},{"key":"4677_CR31","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1007\/s00134-015-3934-7","volume":"41","author":"EAJ Hoste","year":"2015","unstructured":"Hoste EAJ, Bagshaw SM, Bellomo R et al (2015) Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med 41:1411\u20131423. doi: 10.1007\/s00134-015-3934-7","journal-title":"Intensive Care Med"},{"key":"4677_CR32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/SHK.0000000000000052","volume":"41","author":"H Gomez","year":"2014","unstructured":"Gomez H, Ince C, De Backer D et al (2014) A unified theory of sepsis-induced acute kidney injury: inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury. Shock 41:3\u201311. doi: 10.1097\/SHK.0000000000000052","journal-title":"Shock"},{"key":"4677_CR33","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1007\/s00134-014-3313-9","volume":"40","author":"V Pettil\u00e4","year":"2014","unstructured":"Pettil\u00e4 V, Bellomo R (2014) Understanding acute kidney injury in sepsis. Intensive Care Med 40:1018\u20131020. doi: 10.1007\/s00134-014-3313-9","journal-title":"Intensive Care Med"},{"key":"4677_CR34","doi-asserted-by":"publisher","first-page":"R25","DOI":"10.1186\/cc12503","volume":"17","author":"K Kashani","year":"2013","unstructured":"Kashani K, Al-Khafaji A, Ardiles T et al (2013) Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care 17:R25. doi: 10.1186\/cc12503","journal-title":"Crit Care"},{"key":"4677_CR35","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1007\/s00134-010-1887-4","volume":"36","author":"J M\u00e5rtensson","year":"2010","unstructured":"M\u00e5rtensson J, Bell M, Oldner A et al (2010) Neutrophil gelatinase-associated lipocalin in adult septic patients with and without acute kidney injury. Intensive Care Med 36:1333\u20131340. doi: 10.1007\/s00134-010-1887-4","journal-title":"Intensive Care Med"},{"key":"4677_CR36","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1097\/CCM.0000000000001827","volume":"44","author":"PM Honore","year":"2016","unstructured":"Honore PM, Nguyen HB, Gong M et al (2016) Urinary tissue inhibitor of metalloproteinase-2 and insulin-like growth factor-binding protein 7 for risk stratification of acute kidney injury in patients with sepsis. Crit Care Med 44:1851\u20131860. doi: 10.1097\/CCM.0000000000001827","journal-title":"Crit Care Med"},{"key":"4677_CR37","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1007\/s00134-015-3850-x","volume":"41","author":"M Cecconi","year":"2015","unstructured":"Cecconi M, Hofer C, Teboul J-L et al (2015) Fluid challenges in intensive care: the FENICE study: a global inception cohort study. Intensive Care Med 41:1529\u20131537. doi: 10.1007\/s00134-015-3850-x","journal-title":"Intensive Care Med"},{"key":"4677_CR38","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1056\/NEJMoa1312173","volume":"370","author":"P Asfar","year":"2014","unstructured":"Asfar P, Meziani F, Hamel J-F et al (2014) High versus low blood-pressure target in patients with septic shock. N Engl J Med 370:1583\u20131593. doi: 10.1056\/NEJMoa1312173","journal-title":"N Engl J Med"},{"key":"4677_CR39","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13054-016-1253-1","volume":"20","author":"S Saito","year":"2016","unstructured":"Saito S, Uchino S, Takinami M et al (2016) Postoperative blood pressure deficit and acute kidney injury progression in vasopressor-dependent cardiovascular surgery patients. Crit Care 20:74. doi: 10.1186\/s13054-016-1253-1","journal-title":"Crit Care"},{"key":"4677_CR40","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.semnephrol.2016.01.008","volume":"36","author":"BA Molitoris","year":"2016","unstructured":"Molitoris BA, Reilly ES (2016) Quantifying glomerular filtration rates in acute kidney injury: a requirement for translational success. Semin Nephrol 36:31\u201341. doi: 10.1016\/j.semnephrol.2016.01.008","journal-title":"Semin Nephrol"},{"key":"4677_CR41","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s00134-012-2769-8","volume":"39","author":"RP Dellinger","year":"2013","unstructured":"Dellinger RP, Levy MM, Rhodes A et al (2013) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 39:165\u2013228. doi: 10.1007\/s00134-012-2769-8","journal-title":"Intensive Care Med"},{"key":"4677_CR42","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-016-4500-7","author":"PB Hjortrup","year":"2016","unstructured":"Hjortrup PB, Haase N, Bundgaard H et al (2016) Restricting volumes of resuscitation fluid in adults with septic shock after initial management: the CLASSIC randomised, parallel-group, multicentre feasibility trial. Intensive Care Med. doi: 10.1007\/s00134-016-4500-7","journal-title":"Intensive Care Med"},{"key":"4677_CR43","doi-asserted-by":"publisher","first-page":"R278","DOI":"10.1186\/cc13133","volume":"17","author":"M Legrand","year":"2013","unstructured":"Legrand M, Dupuis C, Simon C et al (2013) Association between systemic hemodynamics and septic acute kidney injury in critically ill patients: a retrospective observational study. Crit Care 17:R278. doi: 10.1186\/cc13133","journal-title":"Crit Care"},{"key":"4677_CR44","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1186\/s13054-015-1009-3","volume":"19","author":"SL Jones","year":"2015","unstructured":"Jones SL, Tanaka A, Eastwood GM et al (2015) Bioelectrical impedance vector analysis in critically ill patients: a prospective, clinician-blinded investigation. Crit Care 19:290. doi: 10.1186\/s13054-015-1009-3","journal-title":"Crit Care"},{"key":"4677_CR45","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1097\/01.CCM.0000239119.57544.0C","volume":"34","author":"M-J Dubois","year":"2006","unstructured":"Dubois M-J, Orellana-Jimenez C, Melot C et al (2006) Albumin administration improves organ function in critically ill hypoalbuminemic patients: a prospective, randomized, controlled, pilot study. Crit Care Med 34:2536\u20132540. doi: 10.1097\/01.CCM.0000239119.57544.0C","journal-title":"Crit Care Med"},{"key":"4677_CR46","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1056\/NEJMoa1305727","volume":"370","author":"P Caironi","year":"2014","unstructured":"Caironi P, Tognoni G, Masson S et al (2014) Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med 370:1412\u20131421. doi: 10.1056\/NEJMoa1305727","journal-title":"N Engl J Med"},{"key":"4677_CR47","doi-asserted-by":"crossref","first-page":"f839","DOI":"10.1136\/bmj.f839","volume":"346","author":"N Haase","year":"2013","unstructured":"Haase N, Perner A, Hennings LI et al (2013) Hydroxyethyl starch 130\/0.38-0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis. BMJ 346:f839","journal-title":"BMJ"},{"key":"4677_CR48","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jcrc.2016.04.011","volume":"35","author":"C Moeller","year":"2016","unstructured":"Moeller C, Fleischmann C, Thomas-Rueddel D et al (2016) How safe is gelatin? A systematic review and meta-analysis of gelatin-containing plasma expanders vs crystalloids and albumin. J Crit Care 35:75\u201383. doi: 10.1016\/j.jcrc.2016.04.011","journal-title":"J Crit Care"},{"key":"4677_CR49","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1056\/NEJMoa1204242","volume":"367","author":"A Perner","year":"2012","unstructured":"Perner A, Haase N, Guttormsen AB et al (2012) Hydroxyethyl starch 130\/0.42 versus Ringer\u2019s acetate in severe sepsis. N Engl J Med 367:124\u2013134. doi: 10.1056\/NEJMoa1204242","journal-title":"N Engl J Med"},{"key":"4677_CR50","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1097\/CCM.0000000000000305","volume":"42","author":"K Raghunathan","year":"2014","unstructured":"Raghunathan K, Shaw A, Nathanson B et al (2014) Association between the choice of IV crystalloid and in-hospital mortality among critically ill adults with sepsis. Crit Care Med 42:1585\u20131591. doi: 10.1097\/CCM.0000000000000305","journal-title":"Crit Care Med"},{"key":"4677_CR51","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1001\/jama.2015.12334","volume":"314","author":"P Young","year":"2015","unstructured":"Young P, Bailey M, Beasley R et al (2015) Effect of a buffered crystalloid solution vs saline on acute kidney injury among patients in the intensive care Unit: the SPLIT randomized clinical trial. JAMA 314:1701\u20131710. doi: 10.1001\/jama.2015.12334","journal-title":"JAMA"},{"key":"4677_CR52","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1097\/CCM.0000000000000715","volume":"43","author":"CK Grissom","year":"2015","unstructured":"Grissom CK, Hirshberg EL, Dickerson JB et al (2015) Fluid management with a simplified conservative protocol for the acute respiratory distress syndrome. Crit Care Med 43:288\u2013295. doi: 10.1097\/CCM.0000000000000715","journal-title":"Crit Care Med"},{"key":"4677_CR53","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1681\/ASN.2014060535","volume":"26","author":"JL Koyner","year":"2015","unstructured":"Koyner JL, Davison DL, Brasha-Mitchell E et al (2015) Furosemide stress test and biomarkers for the prediction of AKI severity. J Am Soc Nephrol 26:2023\u20132031. doi: 10.1681\/ASN.2014060535","journal-title":"J Am Soc Nephrol"},{"key":"4677_CR54","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s00134-012-2706-x","volume":"39","author":"M Legrand","year":"2013","unstructured":"Legrand M, Darmon M, Joannidis M, Payen D (2013) Management of renal replacement therapy in ICU patients: an international survey. Intensive Care Med 39:101\u2013108. doi: 10.1007\/s00134-012-2706-x","journal-title":"Intensive Care Med"},{"key":"4677_CR55","first-page":"1","volume":"Suppl 2","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group","year":"2012","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group (2012) KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2:1\u2013138","journal-title":"Kidney Int"},{"key":"4677_CR56","unstructured":"KDIGO (2016) KDIGO clinical practice guideline for acute kidney injury http:\/\/www.kdigo.org\/clinical_practice_guidelines\/pdf\/KDIGO%20AKI%20Guideline.pdf . Accessed 11 Oct 2016"},{"key":"4677_CR57","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1159\/000448506","volume":"42","author":"M Ostermann","year":"2016","unstructured":"Ostermann M, Joannidis M, Pani A et al (2016) Patient selection and timing of continuous renal replacement therapy. Blood Purif 42:224\u2013237. doi: 10.1159\/000448506","journal-title":"Blood Purif"},{"key":"4677_CR58","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1097\/CCM.0b013e3181962316","volume":"37","author":"D Payen","year":"2009","unstructured":"Payen D, Mateo J, Cavaillon JM et al (2009) Impact of continuous venovenous hemofiltration on organ failure during the early phase of severe sepsis: a randomized controlled trial. Crit Care Med 37:803\u2013810. doi: 10.1097\/CCM.0b013e3181962316","journal-title":"Crit Care Med"},{"key":"4677_CR59","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1056\/NEJMoa1603017","volume":"375","author":"S Gaudry","year":"2016","unstructured":"Gaudry S, Hajage D, Schortgen F et al (2016) Initiation strategies for renal-replacement therapy in the intensive care unit. N Engl J Med 375:122\u2013133. doi: 10.1056\/NEJMoa1603017","journal-title":"N Engl J Med"},{"key":"4677_CR60","first-page":"595","volume":"80","author":"GF Lehner","year":"2014","unstructured":"Lehner GF, Wiedermann CJ, Joannidis M (2014) High-volume hemofiltration in critically ill patients: a systematic review and meta-analysis. Minerva Anestesiol 80:595\u2013609","journal-title":"Minerva Anestesiol"},{"key":"4677_CR61","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1056\/NEJMoa1102662","volume":"365","author":"MP Casaer","year":"2011","unstructured":"Casaer MP, Mesotten D, Hermans G et al (2011) Early versus late parenteral nutrition in critically ill adults. N Engl J Med 365:506\u2013517. doi: 10.1056\/NEJMoa1102662","journal-title":"N Engl J Med"},{"key":"4677_CR62","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1056\/NEJMoa1502826","volume":"372","author":"YM Arabi","year":"2015","unstructured":"Arabi YM, Aldawood AS, Haddad SH et al (2015) Permissive underfeeding or standard enteral feeding in critically ill adults. N Engl J Med 372:2398\u20132408. doi: 10.1056\/NEJMoa1502826","journal-title":"N Engl J Med"},{"key":"4677_CR63","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1093\/bja\/aeu187","volume":"113","author":"J-C Preiser","year":"2014","unstructured":"Preiser J-C, Ichai C, Orban J-C, Groeneveld ABJ (2014) Metabolic response to the stress of critical illness. Br J Anaesth 113:945\u2013954. doi: 10.1093\/bja\/aeu187","journal-title":"Br J Anaesth"},{"key":"4677_CR64","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1056\/NEJMoa1514762","volume":"374","author":"T Fivez","year":"2016","unstructured":"Fivez T, Kerklaan D, Mesotten D et al (2016) Early versus late parenteral nutrition in critically ill children. N Engl J Med 374:1111\u20131122. doi: 10.1056\/NEJMoa1514762","journal-title":"N Engl J Med"},{"key":"4677_CR65","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1056\/NEJMoa1212722","volume":"368","author":"D Heyland","year":"2013","unstructured":"Heyland D, Muscedere J, Wischmeyer PE et al (2013) A randomized trial of glutamine and antioxidants in critically ill patients. N Engl J Med 368:1489\u20131497. doi: 10.1056\/NEJMoa1212722","journal-title":"N Engl J Med"},{"key":"4677_CR66","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1001\/jama.2014.7698","volume":"312","author":"ARH Zanten van","year":"2014","unstructured":"van Zanten ARH, Sztark F, Kaisers UX et al (2014) High-protein enteral nutrition enriched with immune-modulating nutrients vs standard high-protein enteral nutrition and nosocomial infections in the ICU: a randomized clinical trial. JAMA 312:514\u2013524. doi: 10.1001\/jama.2014.7698","journal-title":"JAMA"},{"key":"4677_CR67","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/S2213-2600(15)00418-X","volume":"3","author":"GS Doig","year":"2015","unstructured":"Doig GS, Simpson F, Heighes PT et al (2015) Restricted versus continued standard caloric intake during the management of refeeding syndrome in critically ill adults: a randomised, parallel-group, multicentre, single-blind controlled trial. Lancet Respir Med 3:943\u2013952. doi: 10.1016\/S2213-2600(15)00418-X","journal-title":"Lancet Respir Med"},{"key":"4677_CR68","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/01.CCM.0000251124.83436.0E","volume":"35","author":"MWA Angstwurm","year":"2007","unstructured":"Angstwurm MWA, Engelmann L, Zimmermann T et al (2007) Selenium in intensive care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock. Crit Care Med 35:118\u2013126. doi: 10.1097\/01.CCM.0000251124.83436.0E","journal-title":"Crit Care Med"},{"key":"4677_CR69","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1001\/jamainternmed.2016.2514","volume":"176","author":"F Bloos","year":"2016","unstructured":"Bloos F, Trips E, Nierhaus A et al (2016) Effect of sodium selenite administration and procalcitonin-guided therapy on mortality in patients with severe sepsis or septic shock: a randomized clinical trial. JAMA Intern Med 176:1266\u20131276. doi: 10.1001\/jamainternmed.2016.2514","journal-title":"JAMA Intern Med"},{"key":"4677_CR70","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1177\/0148607113495414","volume":"38","author":"MA Puskarich","year":"2014","unstructured":"Puskarich MA, Kline JA, Krabill V et al (2014) Preliminary safety and efficacy of L-carnitine infusion for the treatment of vasopressor-dependent septic shock: a randomized control trial. JPEN J Parenter Enter Nutr 38:736\u2013743. doi: 10.1177\/0148607113495414","journal-title":"JPEN J Parenter Enter Nutr"},{"key":"4677_CR71","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1007\/s00134-016-4303-x","volume":"42","author":"J Zeng","year":"2016","unstructured":"Zeng J, Wang C-T, Zhang F-S et al (2016) Effect of probiotics on the incidence of ventilator-associated pneumonia in critically ill patients: a randomized controlled multicenter trial. Intensive Care Med 42:1018\u20131028. doi: 10.1007\/s00134-016-4303-x","journal-title":"Intensive Care Med"},{"key":"4677_CR72","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1056\/NEJMcibr1004371","volume":"363","author":"RS Hotchkiss","year":"2010","unstructured":"Hotchkiss RS, Opal S (2010) Immunotherapy for sepsis\u2014a new approach against an ancient foe. N Engl J Med 363:87\u201389. doi: 10.1056\/NEJMcibr1004371","journal-title":"N Engl J Med"},{"key":"4677_CR73","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/S1473-3099(07)70290-6","volume":"7","author":"NG Rouphael","year":"2007","unstructured":"Rouphael NG, Talati NJ, Vaughan C et al (2007) Infections associated with haemophagocytic syndrome. Lancet Infect Dis 7:814\u2013822. doi: 10.1016\/S1473-3099(07)70290-6","journal-title":"Lancet Infect Dis"},{"key":"4677_CR74","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1093\/rheumatology\/keq218","volume":"50","author":"PM Miettunen","year":"2011","unstructured":"Miettunen PM, Narendran A, Jayanthan A et al (2011) Successful treatment of severe paediatric rheumatic disease-associated macrophage activation syndrome with interleukin-1 inhibition following conventional immunosuppressive therapy: case series with 12 patients. Rheumatology (Oxford) 50:417\u2013419. doi: 10.1093\/rheumatology\/keq218","journal-title":"Rheumatology (Oxford)"},{"key":"4677_CR75","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1001\/jamasurg.2013.4841","volume":"149","author":"EM Bulger","year":"2014","unstructured":"Bulger EM, Maier RV, Sperry J et al (2014) A novel drug for treatment of necrotizing soft-tissue infections: a randomized clinical trial. JAMA Surg 149:528\u2013536. doi: 10.1001\/jamasurg.2013.4841","journal-title":"JAMA Surg"},{"key":"4677_CR76","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1124\/jpet.112.198226","volume":"344","author":"E Peters","year":"2013","unstructured":"Peters E, van Elsas A, Heemskerk S et al (2013) Alkaline phosphatase as a treatment of sepsis-associated acute kidney injury. J Pharmacol Exp Ther 344:2\u20137. doi: 10.1124\/jpet.112.198226","journal-title":"J Pharmacol Exp Ther"},{"key":"4677_CR77","doi-asserted-by":"publisher","first-page":"e012371","DOI":"10.1136\/bmjopen-2016-012371","volume":"6","author":"E Peters","year":"2016","unstructured":"Peters E, Mehta RL, Murray PT et al (2016) Study protocol for a multicentre randomised controlled trial: safety, tolerability, efficacy and quality of life Of a human recombinant alkaline phosphatase in patients with sepsis-associated acute kidney injury (STOP-AKI). BMJ Open 6:e012371. doi: 10.1136\/bmjopen-2016-012371","journal-title":"BMJ Open"},{"key":"4677_CR78","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/cc9411","volume":"15","author":"T Rimmel\u00e9","year":"2011","unstructured":"Rimmel\u00e9 T, Kellum JA (2011) Clinical review: blood purification for sepsis. Crit Care 15:205. doi: 10.1186\/cc9411","journal-title":"Crit Care"},{"key":"4677_CR79","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/nm.3640","volume":"20","author":"JH Kang","year":"2014","unstructured":"Kang JH, Super M, Yung CW et al (2014) An extracorporeal blood-cleansing device for sepsis therapy. Nat Med 20:1211\u20131216. doi: 10.1038\/nm.3640","journal-title":"Nat Med"},{"key":"4677_CR80","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/SHK.0000000000000317","volume":"43","author":"Y Shindo","year":"2015","unstructured":"Shindo Y, Unsinger J, Burnham C-A et al (2015) Interleukin-7 and anti-programmed cell death 1 antibody have differing effects to reverse sepsis-induced immunosuppression. Shock 43:334\u2013343. doi: 10.1097\/SHK.0000000000000317","journal-title":"Shock"},{"key":"4677_CR81","doi-asserted-by":"crossref","first-page":"16045","DOI":"10.1038\/nrdp.2016.45","volume":"2","author":"RS Hotchkiss","year":"2016","unstructured":"Hotchkiss RS, Moldawer LL, Opal SM et al (2016) Sepsis and septic shock. Nat Rev Dis Primer 2:16045","journal-title":"Nat Rev Dis Primer"},{"key":"4677_CR82","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1056\/NEJMcibr1404664","volume":"371","author":"RS Hotchkiss","year":"2014","unstructured":"Hotchkiss RS, Moldawer LL (2014) Parallels between cancer and infectious disease. N Engl J Med 371:380\u2013383. doi: 10.1056\/NEJMcibr1404664","journal-title":"N Engl J Med"},{"key":"4677_CR83","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1128\/AAC.03923-14","volume":"59","author":"A Chahin","year":"2015","unstructured":"Chahin A, Opal SM, Zorzopulos J et al (2015) The novel immunotherapeutic oligodeoxynucleotide IMT504 protects neutropenic animals from fatal Pseudomonas aeruginosa bacteremia and sepsis. Antimicrob Agents Chemother 59:1225\u20131229. doi: 10.1128\/AAC.03923-14","journal-title":"Antimicrob Agents Chemother"},{"key":"4677_CR84","doi-asserted-by":"publisher","first-page":"e2044","DOI":"10.1097\/MD.0000000000002044","volume":"94","author":"B Mathias","year":"2015","unstructured":"Mathias B, Szpila BE, Moore FA et al (2015) A review of GM-CSF therapy in sepsis. Medicine (Baltimore) 94:e2044. doi: 10.1097\/MD.0000000000002044","journal-title":"Medicine (Baltimore)"},{"key":"4677_CR85","doi-asserted-by":"publisher","first-page":"R8","DOI":"10.1186\/cc11932","volume":"17","author":"J Wu","year":"2013","unstructured":"Wu J, Zhou L, Liu J et al (2013) The efficacy of thymosin alpha 1 for severe sepsis (ETASS): a multicenter, single-blind, randomized and controlled trial. Crit Care 17:R8. doi: 10.1186\/cc11932","journal-title":"Crit Care"},{"key":"4677_CR86","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1001\/jamainternmed.2016.2514","volume":"176","author":"F Bloos","year":"2016","unstructured":"Bloos F, Trips E, Nierhaus A et al (2016) Effect of sodium selenite administration and procalcitonin-guided therapy on mortality in patients with severe sepsis or septic shock: a randomized clinical trial. JAMA Intern Med 176:1266\u20131276. doi: 10.1001\/jamainternmed.2016.2514","journal-title":"JAMA Intern Med"},{"key":"4677_CR87","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1128\/CMR.00016-12","volume":"25","author":"K Reinhart","year":"2012","unstructured":"Reinhart K, Bauer M, Riedemann NC, Hartog CS (2012) New approaches to sepsis: molecular diagnostics and biomarkers. Clin Microbiol Rev 25:609\u2013634. doi: 10.1128\/CMR.00016-12","journal-title":"Clin Microbiol Rev"},{"key":"4677_CR88","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S2213-2600(16)00046-1","volume":"4","author":"EE Davenport","year":"2016","unstructured":"Davenport EE, Burnham KL, Radhakrishnan J et al (2016) Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study. Lancet Respir Med 4:259\u2013271. doi: 10.1016\/S2213-2600(16)00046-1","journal-title":"Lancet Respir Med"},{"key":"4677_CR89","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S1473-3099(15)70112-X","volume":"15","author":"J Cohen","year":"2015","unstructured":"Cohen J, Vincent J-L, Adhikari NKJ et al (2015) Sepsis: a roadmap for future research. Lancet Infect Dis 15:581\u2013614. doi: 10.1016\/S1473-3099(15)70112-X","journal-title":"Lancet Infect Dis"},{"key":"4677_CR90","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1097\/CCM.0b013e3181b785a2","volume":"38","author":"J-L Vincent","year":"2010","unstructured":"Vincent J-L, Opal SM, Marshall JC (2010) Ten reasons why we should NOT use severity scores as entry criteria for clinical trials or in our treatment decisions. Crit Care Med 38:283\u2013287. doi: 10.1097\/CCM.0b013e3181b785a2","journal-title":"Crit Care Med"},{"key":"4677_CR91","unstructured":"ClinicalTrials.gov (2016) Phase 3 safety and efficacy study of ART-123 in subjects with severe sepsis and coagulopathy. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01598831 . Accessed 12 Oct 2016"},{"key":"4677_CR92","unstructured":"ClinicalTrials.gov (2016) GM-CSF to decrease ICU acquired infections. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02361528?term=NCT02361528&rank=1 . Accessed 12 Oct 2016"},{"key":"4677_CR93","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1007\/s00134-014-3496-0","volume":"40","author":"MM Levy","year":"2014","unstructured":"Levy MM, Rhodes A, Phillips GS et al (2014) Surviving Sepsis Campaign: association between performance metrics and outcomes in a 7.5-year study. Intensive Care Med 40:1623\u20131633. doi: 10.1007\/s00134-014-3496-0","journal-title":"Intensive Care Med"},{"key":"4677_CR94","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1097\/01.CCM.0000174478.70338.03","volume":"33","author":"JC Marshall","year":"2005","unstructured":"Marshall JC, Vincent J-L, Guyatt G et al (2005) Outcome measures for clinical research in sepsis: a report of the 2nd Cambridge Colloquium of the international sepsis forum. Crit Care Med 33:1708\u20131716","journal-title":"Crit Care Med"},{"issue":"Suppl 1","key":"4677_CR95","doi-asserted-by":"publisher","first-page":"S52","DOI":"10.1086\/338061","volume":"185","author":"JP Siegel","year":"2002","unstructured":"Siegel JP (2002) Biotechnology and clinical trials. J Infect Dis 185(Suppl 1):S52\u2013S57. doi: 10.1086\/338061","journal-title":"J Infect Dis"},{"key":"4677_CR96","doi-asserted-by":"publisher","first-page":"431","DOI":"10.2215\/CJN.03681106","volume":"2","author":"SM Bagshaw","year":"2007","unstructured":"Bagshaw SM, Uchino S, Bellomo R et al (2007) Septic acute kidney injury in critically ill patients: clinical characteristics and outcomes. Clin J Am Soc Nephrol 2:431\u2013439. doi: 10.2215\/CJN.03681106","journal-title":"Clin J Am Soc Nephrol"},{"key":"4677_CR97","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1213\/ANE.0b013e31820bd185","volume":"112","author":"A Afshari","year":"2011","unstructured":"Afshari A, Brok J, M\u00f8ller AM, Wetterslev J (2011) Inhaled nitric oxide for acute respiratory distress syndrome and acute lung injury in adults and children: a systematic review with meta-analysis and trial sequential analysis. Anesth Analg 112:1411\u20131421. doi: 10.1213\/ANE.0b013e31820bd185","journal-title":"Anesth Analg"},{"key":"4677_CR98","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1097\/CCM.0000000000001658","volume":"44","author":"S Yende","year":"2016","unstructured":"Yende S, Austin S, Rhodes A et al (2016) Long-term quality of life among survivors of severe sepsis: analyses of two international trials. Crit Care Med 44:1461\u20131467. doi: 10.1097\/CCM.0000000000001658","journal-title":"Crit Care Med"},{"key":"4677_CR99","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1164\/rccm.201206-1057OC","volume":"187","author":"ND Ferguson","year":"2013","unstructured":"Ferguson ND, Scales DC, Pinto R et al (2013) Integrating mortality and morbidity outcomes: using quality-adjusted life years in critical care trials. Am J Respir Crit Care Med 187:256\u2013261. doi: 10.1164\/rccm.201206-1057OC","journal-title":"Am J Respir Crit Care Med"},{"key":"4677_CR100","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1164\/rccm.201504-0781OC","volume":"193","author":"C Fleischmann","year":"2016","unstructured":"Fleischmann C, Scherag A, Adhikari NKJ et al (2016) Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations. Am J Respir Crit Care Med 193:259\u2013272. doi: 10.1164\/rccm.201504-0781OC","journal-title":"Am J Respir Crit Care Med"},{"key":"4677_CR101","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3238\/arztebl.2016.0159","volume":"113","author":"C Fleischmann","year":"2016","unstructured":"Fleischmann C, Thomas-Rueddel DO, Hartmann M et al (2016) Hospital incidence and mortality rates of sepsis. Dtsch \u00c4rztebl Int 113:159\u2013166. doi: 10.3238\/arztebl.2016.0159","journal-title":"Dtsch \u00c4rztebl Int"},{"key":"4677_CR102","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1007\/s00134-015-3822-1","volume":"41","author":"DC Angus","year":"2015","unstructured":"Angus DC, Barnato AE, Bell D et al (2015) A systematic review and meta-analysis of early goal-directed therapy for septic shock: the ARISE, ProCESS and ProMISe investigators. Intensive Care Med 41:1549\u20131560. doi: 10.1007\/s00134-015-3822-1","journal-title":"Intensive Care Med"},{"key":"4677_CR103","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1007\/s00134-015-3906-y","volume":"41","author":"A Rhodes","year":"2015","unstructured":"Rhodes A, Phillips G, Beale R et al (2015) The Surviving Sepsis Campaign bundles and outcome: results from the international multicentre prevalence study on sepsis (the IMPreSS study). Intensive Care Med 41:1620\u20131628. doi: 10.1007\/s00134-015-3906-y","journal-title":"Intensive Care Med"},{"key":"4677_CR104","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1001\/jama.2014.2637","volume":"311","author":"K-M Kaukonen","year":"2014","unstructured":"Kaukonen K-M, Bailey M, Suzuki S et al (2014) Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000\u20132012. JAMA 311:1308\u20131316. doi: 10.1001\/jama.2014.2637","journal-title":"JAMA"},{"key":"4677_CR105","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000001876","author":"M Shankar-Hari","year":"2016","unstructured":"Shankar-Hari M, Harrison DA, Rowan KM (2016) Differences in Impact of definitional elements on mortality precludes international comparisons of sepsis epidemiology-a cohort study illustrating the need for standardized reporting. Crit Care Med. doi: 10.1097\/CCM.0000000000001876","journal-title":"Crit Care Med"},{"key":"4677_CR106","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1007\/s00134-016-4504-3","volume":"42","author":"SepNet Critical Care Trials Group","year":"2016","unstructured":"SepNet Critical Care Trials Group (2016) Incidence of severe sepsis and septic shock in German intensive care units: the prospective, multicentre INSEP study. Intensive Care Med 42:1980\u20131989. doi: 10.1007\/s00134-016-4504-3","journal-title":"Intensive Care Med"},{"key":"4677_CR107","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1056\/NEJMoa070716","volume":"358","author":"FM Brunkhorst","year":"2008","unstructured":"Brunkhorst FM, Engel C, Bloos F et al (2008) Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 358:125\u2013139. doi: 10.1056\/NEJMoa070716","journal-title":"N Engl J Med"},{"key":"4677_CR108","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1056\/NEJMoa1406617","volume":"371","author":"LB Holst","year":"2014","unstructured":"Holst LB, Haase N, Wetterslev J et al (2014) Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med 371:1381\u20131391. doi: 10.1056\/NEJMoa1406617","journal-title":"N Engl J Med"},{"key":"4677_CR109","doi-asserted-by":"publisher","unstructured":"Hammond NE, Taylor C, Saxena M et al (2015) Resuscitation fluid use in Australian and New Zealand Intensive Care Units between 2007 and 2013. Intensive Care Med 41:1611\u20139. doi: 10.1007\/s00134-015-3878-y","DOI":"10.1007\/s00134-015-3878-y"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-017-4677-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00134-017-4677-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-017-4677-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T05:10:31Z","timestamp":1498367431000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00134-017-4677-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,27]]},"references-count":109,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["4677"],"URL":"https:\/\/doi.org\/10.1007\/s00134-017-4677-4","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,27]]}}}